Bionano Genomics (BNGO) Expected to Announce Quarterly Earnings on Wednesday

Bionano Genomics (NASDAQ:BNGO) is anticipated to issue its quarterly earnings data before the market opens on Wednesday, March 12th. Analysts expect the company to announce earnings of ($8.40) per share and revenue of $6.20 million for the quarter.

Bionano Genomics Price Performance

Shares of BNGO opened at $4.08 on Monday. Bionano Genomics has a 12-month low of $3.73 and a 12-month high of $75.60. The business’s fifty day moving average is $8.46 and its 200 day moving average is $16.00. The company has a quick ratio of 0.99, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The stock has a market cap of $11.15 million, a P/E ratio of -0.03 and a beta of 2.24.

Analyst Ratings Changes

Separately, LADENBURG THALM/SH SH cut Bionano Genomics from a “buy” rating to a “neutral” rating in a report on Friday, November 15th.

About Bionano Genomics

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.